Are you Dr. Brewster?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 100 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Abenaa Brewster, MD is an oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Florida, and Oklahoma. She is affiliated with University of Texas M.D. Anderson Cancer Center and is an Associate Professor of Medicine at University Tex Houston.
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1998 - 2002
- Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
- Harvard Medical SchoolClass of 1995
Certifications & Licensure
- FL State Medical License 2021 - Present
- TX State Medical License 2002 - 2025
- OK State Medical License 2020 - 2021
- MD State Medical License 1998 - 2002
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Breast Cancers: Risk Factors Among Mexican Women in Mexico, Mexican-American and African-American Women in the U.S. Start of enrollment: 2007 Jan 01
- Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM) Start of enrollment: 2014 Feb 24
- Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer Start of enrollment: 2017 Apr 28
Publications & Presentations
PubMed
- Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 Trial.Jay P Reddy, Alexander D Sherry, Bryan Fellman, Suyu Liu, Tharakeswara Bathala
International Journal of Radiation Oncology, Biology, Physics. 2024-10-30 - Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study.Clinton Yam, Miral Patel, Holly A Hill, Ryan Sun, Roland L Bassett Jr
Cancer Research Communications. 2024-10-01 - Outcomes for breast cancer survivors with metastatic disease in a physical activity program for medically underserved cancer survivors.Che Young Lee, Kylee Laffoon, Scherezade K Mama, Yue Liao, Meagan Whisenant
Journal of Cancer Survivorship. 2024-05-27
Press Mentions
- MD Anderson Research Highlights: ASCO 2023 Special EditionMay 25th, 2023
- Black Women and the Breast Cancer Disparity ExplainedOctober 7th, 2021
- Could Your Hair Coloring Routine Affect Your Breast Cancer Risk?December 11th, 2019
- Join now to see all
Professional Memberships
- Member